ATE447405T1 - Verbesserung der lernfähigkeit und des gedächtnisses und amnesie-behandlung - Google Patents
Verbesserung der lernfähigkeit und des gedächtnisses und amnesie-behandlungInfo
- Publication number
- ATE447405T1 ATE447405T1 AT02763634T AT02763634T ATE447405T1 AT E447405 T1 ATE447405 T1 AT E447405T1 AT 02763634 T AT02763634 T AT 02763634T AT 02763634 T AT02763634 T AT 02763634T AT E447405 T1 ATE447405 T1 AT E447405T1
- Authority
- AT
- Austria
- Prior art keywords
- sub
- memory
- learning ability
- independently
- improve learning
- Prior art date
Links
- 208000000044 Amnesia Diseases 0.000 title abstract 3
- 208000031091 Amnestic disease Diseases 0.000 title abstract 3
- 230000006986 amnesia Effects 0.000 title abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- 230000002708 enhancing effect Effects 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 125000002541 furyl group Chemical group 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000000168 pyrrolyl group Chemical group 0.000 abstract 1
- 125000001544 thienyl group Chemical group 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4162—1,2-Diazoles condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32238901P | 2001-09-14 | 2001-09-14 | |
| US10/242,826 US7049334B2 (en) | 2001-09-14 | 2002-09-13 | Enhancement of learning and memory and treatment of amnesia |
| PCT/US2002/029294 WO2003024397A2 (en) | 2001-09-14 | 2002-09-16 | Enhancement of learning and memory and treatment of amnesia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE447405T1 true ATE447405T1 (de) | 2009-11-15 |
Family
ID=26935379
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02763634T ATE447405T1 (de) | 2001-09-14 | 2002-09-16 | Verbesserung der lernfähigkeit und des gedächtnisses und amnesie-behandlung |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US7049334B2 (https=) |
| EP (1) | EP1425011B1 (https=) |
| JP (1) | JP2005502722A (https=) |
| KR (1) | KR100889515B1 (https=) |
| AT (1) | ATE447405T1 (https=) |
| AU (1) | AU2002327635B2 (https=) |
| CA (1) | CA2460005C (https=) |
| DE (1) | DE60234263D1 (https=) |
| NZ (1) | NZ532022A (https=) |
| WO (1) | WO2003024397A2 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040077702A1 (en) * | 2001-09-14 | 2004-04-22 | Wen-Mei Fu | Treatment of nuerodegenerative diseases |
| AU2004275694B2 (en) | 2003-06-30 | 2008-03-06 | Bizbiotech Co., Ltd. | Compounds, compositions and methods |
| JP2005089457A (ja) * | 2003-09-03 | 2005-04-07 | Yung Shin Pharmaceutical Industry Co Ltd | 骨成長を促進するまたは骨吸収を阻害するための薬剤組成物 |
| US6984652B2 (en) | 2003-09-05 | 2006-01-10 | Warner-Lambert Company Llc | Gyrase inhibitors |
| AU2007276763B2 (en) * | 2006-07-24 | 2011-03-17 | University Of Maryland, Baltimore | Heme oxygenase inhibitors and methods of therapeutic use |
| EP2106445A2 (en) * | 2006-12-01 | 2009-10-07 | Loma Linda University Medical Center | Inhibition of brain enzymes involved in cerebral amyloid angiopathy and macular degeneration |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5240947A (en) * | 1992-11-30 | 1993-08-31 | National Science Council | 2,3,4,5-substituted furo[2,3-c]pyrazole derivatives |
| JP2928079B2 (ja) * | 1994-02-14 | 1999-07-28 | 永信薬品工業股▲ふん▼有限公司 | １−（置換ベンジル）−３−（置換アリール）縮合ピラゾール類、その製造法及びその用途 |
| US7115661B1 (en) * | 1999-12-29 | 2006-10-03 | Queen's University At Kingston | Methods and compositions for mitigating pain |
| DE19642255A1 (de) * | 1996-10-14 | 1998-04-16 | Bayer Ag | Verwendung von 1-Benzyl-3-(substituierten-hetaryl) -kondensierten Pyrazol-Derivaten |
| DE19744026A1 (de) * | 1997-10-06 | 1999-04-08 | Hoechst Marion Roussel De Gmbh | Pyrazol-Derivate, ihre Herstellung und ihre Verwendung in Arzneimitteln |
| GB9920566D0 (en) * | 1999-08-31 | 1999-11-03 | Univ London | Screen for axon viability |
| JP2004508279A (ja) * | 2000-01-26 | 2004-03-18 | シーダース シナイ メディカル センター | 薬剤を異常脳領域及び／又は悪性腫瘍にデリバリーするためにカリウムチャンネル活性化を用いる方法 |
| AR031176A1 (es) * | 2000-11-22 | 2003-09-10 | Bayer Ag | Nuevos derivados de pirazolpiridina sustituidos con piridina |
-
2002
- 2002-09-13 US US10/242,826 patent/US7049334B2/en not_active Expired - Lifetime
- 2002-09-16 AU AU2002327635A patent/AU2002327635B2/en not_active Ceased
- 2002-09-16 EP EP02763634A patent/EP1425011B1/en not_active Expired - Lifetime
- 2002-09-16 KR KR10-2004-7003743A patent/KR100889515B1/ko not_active Expired - Lifetime
- 2002-09-16 NZ NZ532022A patent/NZ532022A/en unknown
- 2002-09-16 JP JP2003528495A patent/JP2005502722A/ja active Pending
- 2002-09-16 DE DE60234263T patent/DE60234263D1/de not_active Expired - Lifetime
- 2002-09-16 AT AT02763634T patent/ATE447405T1/de not_active IP Right Cessation
- 2002-09-16 WO PCT/US2002/029294 patent/WO2003024397A2/en not_active Ceased
- 2002-09-16 CA CA002460005A patent/CA2460005C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1425011B1 (en) | 2009-11-04 |
| US20030105149A1 (en) | 2003-06-05 |
| EP1425011A2 (en) | 2004-06-09 |
| AU2002327635B2 (en) | 2007-12-13 |
| WO2003024397A3 (en) | 2003-11-06 |
| NZ532022A (en) | 2005-12-23 |
| CA2460005A1 (en) | 2003-03-27 |
| KR20040049307A (ko) | 2004-06-11 |
| CA2460005C (en) | 2008-12-02 |
| DE60234263D1 (de) | 2009-12-17 |
| WO2003024397A2 (en) | 2003-03-27 |
| KR100889515B1 (ko) | 2009-03-19 |
| US7049334B2 (en) | 2006-05-23 |
| JP2005502722A (ja) | 2005-01-27 |
| EP1425011A4 (en) | 2007-09-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1108367T1 (el) | Φαινυλο-καρβοξαμιδικες ενωσεις χρησιμες για την αντιμετωπιση πονου | |
| MXPA02012034A (es) | Derivados de tiofeno utiles como agentes anticancerosos. | |
| EA200100412A1 (ru) | Замещенные 3-цианохинолины в качестве ингибиторов протеинтирозинкиназ | |
| NO20054970L (no) | Arylsubstituerte byrazolforbindelser anvendbare som kinaseinhibitorer | |
| NO20003233D0 (no) | 4-hydrokykinolin-3-karboksamider og hydraziner som antivirale midler | |
| ATE477256T1 (de) | Thienylverbindungen | |
| DK1432705T3 (da) | Antibiotika med dobbeltvirkning | |
| DE602004019548D1 (de) | Kondensierte heterocyclen als inhibitoren von glutamatracemase (muri) | |
| ATE303384T1 (de) | 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren | |
| NO20033959L (no) | Benzimidazoler som er nyttige i behandling av seksuell dysfunksjon | |
| ATE362366T1 (de) | Verwendung von isothiazolderivaten als ureaseinhibitoren zur behandlung von helicobacter pylori verursachte gastrointestinale krankheiten | |
| ATE447405T1 (de) | Verbesserung der lernfähigkeit und des gedächtnisses und amnesie-behandlung | |
| DE69808099D1 (de) | Substituierte 6-alkylphenanthridine | |
| TW200510329A (en) | Treatment of neurodegenerative diseases | |
| NO20030500D0 (no) | Dihydroporfyrinderivater og deres anvendelse | |
| DK1651596T3 (da) | Hidtil ukendte derivater af 4,4'-dithiobis-(3-aminobutan-1-sulfonater) og sammensætninger, der omfatter samme | |
| JP2005502722A5 (https=) | ||
| TW200510330A (en) | Enhancement of bone growth and inhibition of bone resorption | |
| TW200724137A (en) | Cancer treatment | |
| ATE401329T1 (de) | Neue antivirale makrocyclische derivate und metallkomplexe, in die verbrückte makrocyclen eingebaut sind | |
| HRP20050126B1 (hr) | Fungicidne smjese bazirane na ditianonu | |
| TH31815A (th) | สารผสมฆ่าราที่ประกอบด้วย 3-เฟนิลพิเรโซล | |
| EA200600614A1 (ru) | Фунгицидные смеси для борьбы с патогенами риса | |
| EA200600831A1 (ru) | Фунгицидные смеси, в частности, для борьбы с патогенами риса |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |